Expression of Programmed Death Ligand-2 is associated with Prognosis in Nasopharyngeal Carcinoma Microenviroment

Background: Although immune checkpoint inhibitors have opened a new mode of treatment for solid tumors, their efficacy in nasopharyngeal carcinoma (NPC) needs to be further investigated. Inhibitors of the PD-1/PD-L1 immune checkpoint are one of the hot topics in tumor immunotherapy. Programmed death...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Aixin, Wu, Weijun, Deng, Shengling, Yang, Qiao, He, Junyan, Wu, Haibiao, Wang, Haiyun, Zhang, Jiaxing, Feng, Qisheng, Shao, Jianyong, Zeng, Yixin, Cai, Manbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809305/
https://www.ncbi.nlm.nih.gov/pubmed/36606190
http://dx.doi.org/10.7150/jca.77643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809305/
https://www.ncbi.nlm.nih.gov/pubmed/36606190
http://dx.doi.org/10.7150/jca.77643

Ejemplares similares